Overview

Estrogen Treatment in Acromegalic Women

Status:
Unknown status
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
Phase:
Phase 2
Details
Lead Sponsor:
Université de Montréal
Collaborator:
Novartis